Irene Virgolini, Valentina Ambrosini, Jamshed B Bomanji, Richard P Baum, Stefano Fanti, Michael Gabriel, Nikolaos D Papathanasiou, Giovanna Pepe, Wim Oyen, Clemens De Cristoforo, Arturo Chiti
The aim of these guidelines is to assist nuclear medicine physicians in recommending, performing, reporting and interpreting the results of somatostatin (SST) receptor PET/CT imaging using 68Ga-DOTA-conjugated peptides, analogues of octreotide, that bind to SST receptors. This imaging modality should not be regarded as the only approach to visualizing tumours expressing SST receptors or as excluding other imaging modalities useful for obtaining comparable results. The corresponding guidelines of 111In-pentetreotide scintigraphy imaging have been considered and partially integrated with this text. The same has been done with the relevant and recent literature in this field and the final result has been discussed by distinguished experts.
Nucl Med Commun. 2009 Apr;30(4):281-6
[PMID:
19247211]
J Nucl Med. 2007 Oct;48(10):1741-8
[PMID:
17873136]
Mol Imaging Biol. 2003 Jan-Feb;5(1):42-8
[PMID:
14499161]
J Nucl Med. 1998 Nov;39(11):1913-7
[PMID:
9829583]
Eur J Nucl Med. 1998 Jun;25(6):639-58
[PMID:
9618580]
Eur J Nucl Med. 2001 Dec;28(12):1751-7
[PMID:
11734911]
Eur J Nucl Med Mol Imaging. 2005 Apr;32(4):478-85
[PMID:
15655678]
Eur J Nucl Med Mol Imaging. 2010 Apr;37(4):722-7
[PMID:
20107793]
Cancer. 2008 Jun;112(11):2447-55
[PMID:
18383518]
Semin Nucl Med. 1995 Jul;25(3):251-61
[PMID:
7570044]
Bioconjug Chem. 2004 May-Jun;15(3):554-60
[PMID:
15149183]
Eur J Nucl Med Mol Imaging. 2004 Aug;31(8):1097-104
[PMID:
15029459]
J Nucl Med. 2010 May;51(5):669-73
[PMID:
20395323]
Eur J Nucl Med Mol Imaging. 2008 Aug;35(8):1431-8
[PMID:
18418596]
Nucl Med Biol. 2002 Feb;29(2):147-57
[PMID:
11823119]
Eur J Nucl Med Mol Imaging. 2010 Jan;37(1):49-57
[PMID:
19662413]
Eur J Nucl Med Mol Imaging. 2007 Jul;34(7):982-93
[PMID:
17225119]
Eur J Nucl Med Mol Imaging. 2008 Jan;35(1):72-9
[PMID:
17874094]
Appl Radiat Isot. 2008 Aug;66(8):1091-6
[PMID:
18226535]
Eur J Nucl Med Mol Imaging. 2003 Oct;30(10):1338-47
[PMID:
12937948]
Nucl Med Commun. 2007 Nov;28(11):870-5
[PMID:
17901771]
Eur J Nucl Med Mol Imaging. 2010 Jan;37(1):67-77
[PMID:
19618183]
Eur J Nucl Med Mol Imaging. 2010 May;37(5):1049-62
[PMID:
20306035]
Q J Nucl Med. 2000 Mar;44(1):42-9
[PMID:
10932600]
J Nucl Med. 2001 Jul;42(7):1134-8
[PMID:
11438641]
Biomed Pharmacother. 2008 Dec;62(10):667-71
[PMID:
18358680]
J Nucl Med. 2005 May;46(5):763-9
[PMID:
15872348]
Clin Cancer Res. 1997 Dec;3(12 Pt 1):2385-91
[PMID:
9815638]
J Nucl Med. 2010 Mar;51(3):353-9
[PMID:
20150249]
Endocr Rev. 2003 Aug;24(4):389-427
[PMID:
12920149]
J Nucl Med. 2009 Sep;50(9):1427-34
[PMID:
19690033]
J Nucl Med. 1997 Jun;38(6):853-8
[PMID:
9189129]
Ann Oncol. 2001;12 Suppl 2:S51-61
[PMID:
11762353]
Eur J Nucl Med. 1998 Oct;25(10):1396-403
[PMID:
9818279]
Eur J Nucl Med Mol Imaging. 2010 Jul;37(7):1441-8
[PMID:
20461371]
Eur J Nucl Med. 1993 Aug;20(8):716-31
[PMID:
8404961]
Eur J Nucl Med Mol Imaging. 2007 Oct;34(10):1617-26
[PMID:
17520251]
Eur J Nucl Med Mol Imaging. 2003 May;30(5):781-93
[PMID:
12707737]
J Nucl Med. 2007 Apr;48(4):508-18
[PMID:
17401086]
J Nucl Med. 1995 Apr;36(4):542-9
[PMID:
7699439]
J Nucl Med. 2009 Dec;50(12):1927-32
[PMID:
19910422]
J Nucl Med. 2009 Aug;50(8):1214-21
[PMID:
19617343]
Eur J Nucl Med Mol Imaging. 2010 Jan;37(1):46-8
[PMID:
19690853]
Neuroendocrinology. 2009;90(2):184-9
[PMID:
19713709]
Gallium Radioisotopes
Heterocyclic Compounds, 1-Ring
Humans
Image Interpretation, Computer-Assisted
Injections
Neoplasms
Octreotide
Positron-Emission Tomography
Quality Control
Research Design
Tomography, X-Ray Computed
Gallium Radioisotopes
Heterocyclic Compounds, 1-Ring
1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid
Octreotide
